EMEA

Human Rights Due Diligence and Modern Slavery: Global Expectations for Compliance Programs

Recent disclosures linked to the Epstein case have reignited public scrutiny around reputational risk, third-party relationships, and the hidden vulnerabilities that sit beyond formal contracts [...]
Blog

Key Takeaways from our Webinar: Managing Human Rights and Corruption Risks Across Life Sciences Third Parties

Key Takeaways from our Webinar: Managing Human Rights and Corruption Risks Across Life Sciences Third Parties In Partnership with Ethics and Compliance Switzerland. [...]
Anti-Bribery & Corruption

Anti-Corruption, Fraud & Global Compliance For Life Sciences

We’re proud to sponsor 21st Annual Anti-Corruption, Fraud & Global Compliance for Life Sciences conference on May 5–6, 2026! They’ll be sharing how Ethixbase360 supports life sciences companies[...]
AMERS

Ownership Transparency and Sanctions Risk: Building a Defensible UBO Program

Ultimate beneficial ownership (UBO) has moved from a background AML requirement to a central control for sanctions compliance, export controls, and third-party risk management. [...]
APAC

Human Rights Due Diligence and Modern Slavery: APAC and Global Compliance Expectations

Recent disclosures linked to the Epstein case have reignited public scrutiny around reputational risk, third-party relationships, and the hidden vulnerabilities that sit beyond formal contracts [...]
AMERS

Reputational Risk and Third-Party Exposure: Compliance Lessons from the Epstein Files

Recent disclosures linked to the Epstein case have reignited public scrutiny around reputational risk, third-party relationships, and the hidden vulnerabilities that sit beyond formal contracts [...]
See all Resources